Varicella-zoster virus reactivation after SARS-CoV-2 BNT162b2 mRNA vaccination: Report of 5 cases
Saved in:
Main Authors: | Pedro Rodríguez-Jiménez, MD, PhD (Author), Pablo Chicharro, MD (Author), Luisa-Martos Cabrera, MD (Author), Mireia Seguí, MD (Author), Álvaro Morales-Caballero, MD (Author), Mar Llamas-Velasco, MD, PhD (Author), Javier Sánchez-Pérez, MD, PhD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Varicella zoster virus reactivation and mRNA vaccines as a trigger
by: Iñigo Lladó, MD, et al.
Published: (2021) -
Herpes zoster related hospitalization after inactivated (CoronaVac) and mRNA (BNT162b2) SARS-CoV-2 vaccination: A self-controlled case series and nested case-control study
by: Eric Yuk Fai Wan, PhD, et al.
Published: (2022) -
Erythema multiforme reactions after Pfizer/BioNTech (BNT162b2) and Moderna (mRNA-1273) COVID-19 vaccination: A case series
by: Elif Karatas, MD, et al.
Published: (2023) -
SARS-CoV-2 mRNA vaccination and subsequent herpes zoster: Possible immune reconstitution by mRNA vaccination
by: Mitsuhito Ota, MD, PhD
Published: (2022) -
Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
by: Jose W. Ricardo, MD, et al.
Published: (2021)